glutathione mutations in sclc patients vivo functional screens reveal KEAP1 loss as a driver of chemoresistance in small cell lung cancer Glutathione-Dependent Pathways in Cancer Cells
Glutathione Dependent Pathways in Cancer Cells The Era of Antibody Drug Conjugates in Lung Cancer: Trick or Threat? Differential KEAP1 NRF2 mediated signaling widens the therapeutic window of redox targeting drugs in SCLC therapy Nature Communications Impact of the deletion glutathione S transferase (class Mu) on lung cancer risk among smokers The Egyptian Journal of Bronchology Springer Nature Link Immunotherapy in small cell lung cancer: from molecular promises to clinical challenges Journal for ImmunoTherapy of Cancer
Pay in 4 interest-free payments of $5.19 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11



